Daniel L. Email & Phone Number

Paris, France, Fr

Global support to Ex-US countries, with focus on Europe and Emerging Markets, to maximize end to end execution of Global Market Access & Pricing strategies, plans and tactics across all Dupixent indications and Immunology Portfolio. Lead on strategy development and execution to drive launch excellence in Sub-National Market Access. Responsible for representing one geographical voice (for Europe and Emerging Markets) in the development and implementation of Market Access & Pricing strategies and deliverables. Lead the Liaison team and functions, ensuring coordinated and aligned activity across the Global Market Access & Pricing team. Ensure effective country feedback to shape strategies and access initiatives.

Paris, France, Fr

Responsible to build, tailor and lead the Public Affairs (PA) strategy for hema-oncology assets, as well as engaging with global and regional external stakeholders to support access to innovation for patients. Key accountabilities are monitor and assess PA strategies and tactics, drive the adaptation and the implementation at local level, and strengthen the reputation of the company in the oncology space. Policy issues identifier and patient advocacy supporter. Strong collaboration and co-creation with patient advocacy groups and policymakers/influencer

Paris, France, Fr

Lead and design Latin America (LATAM) Market Access strategy (HEOR, Pricing and Value Proposition) for Specialty Care, Orphan Drugs /Rare Disease, Diabetes, Multiple Sclerosis and Immunology. Support Latam countries in order to ensure product strategy with Global and to highlight, with Global, the local needs to aim access overall region.

Paris, France, Fr

Market Access strategy for Specialty Care (Biotech) and Orphan Drugs. Lysosomal (Genzyme), Multiple Sclerosis (Aubagio and Lemtrada) and Immunology (Atopic Dermatitis and Rheumatoid Arthritis). Rare diseases expert. Responsible for Sanofi Genzyme planning, strategy and implementation of Market Access tactics to aim reimbursement and access to National Formulary, Federal Institutions, Decentralized and Private Market . To develop plans for new products (pipeline) to ensure early and rapid access.

North Chicago, Illinois, Us

Responsible of operations and strategy for Public, Federal and Decentralized (HMOs) Market Access strategy as well as for Private Market Access. Develop and establish Market Access strategies for New Products (Pipeline). To develop Hepatitis C (Viekira Pak) launch plan. Specialty care high cost molecules strategies to increase penetration and take competitive advantage over competitors (Humira, Kaletra, Synagis, Zemplar, among others). Development of biosimilars strategy with a Market Access perspective.

Brentford, Middlesex, Gb

Leader market access strategy related with Public Policy and Lobbying Activities. Development of strategies for market penetration. Responsible for carrying out the submissions to the National and Federal Formularies. Development, in conjunction with Medical Affairs, of the strategies for the inclusion of drugs in medical protocols and guidelines. Development of key HEOR messages with the marketing area for diverse products. Work with KAM representatives in the field in order to share value messages.

Brentford, Middlesex, Gb

Responsible of all related to Health Economics and Outcomes Research (HEOR) for the company (Specialty Care, Primary Care and Vaccines). Development of strategies for market penetration. Development of interactive Cost Effectiveness and Budget Impact Analysis tools for Maket Access purposes for the company's products. Provide training in health economics to company employees, decision makers and physicians. Work with the medical area for the development of HEOR models.

Switzerland 🇨🇭 , Ch

Responsible of all related to Market Access and Pharmacoeconomics of the company.Leader, in conjunction with the Director of the area, of Public Policy and Lobbying Activities.Leader and Regional Coordinator for pharmacoeconomic tools and models to support Latin American affiliates.Development of strategies for market penetration.Responsible for carrying out the submissions to the National and Institutional Formularies.Development of strategies for the inclusion of drugs in medical protocols.Interactive pharmacoeconomic presentations for the company's products.Provide training in health economics to company employees, decision makers and physicians.Work with the medical area for the development of pharmacoeconomic models.Development of key pharmacoeconomic messages for the Marketing area for the products of the company.Publications in international and national conferences and journals.Full knowledge of National Health System and the mapping of stakeholders.Implementation of strategies and communication with patient groups.Involvement of Strategies for biotechnology products not patent.Work with KAM representatives.Develop cost-effectiveness and budget impact models.Design and implement non-interventional retrospective or prospective outcomes studies.Provide input to medical/clinical study plans to support and optimize HE.Develop HE communication in terms of value dossiers, presentations and publications to support market access with key health care decision makers and stakeholders. Liaise and coordinate activities with Public Affairs, Medical, Sales and Marketing.Onco and Specialty Care Health Economics and Access expert. (Mabthera, Herceptin, Tarceva, Xeloda, RoActemra, Zelboraf, Valcyte, Pegasys and Neulastim)Achievements: 3 inclusions in National Formulary and one inclusion at IMSS, all target therapies high cost molecules (Oncology and Rheumatology).

Switzerland 🇨🇭 , Ch

Bilbao, Biscay, Es

Mba

Leadership Program For Health Leaders, Public Health

Bs., Economics